ENOX2 (ecto-NOX disulfide-thiol exchanger 2)
Gene | |
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
10495 |
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Ecto-NOX disulfide-thiol exchanger 2 |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
ENOX2 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
APK1, COVA1, tNOX |
Chromosome
Chromosome number
|
X |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
Xq26.1 |
Summary
Summary of gene provided in NCBI Entrez Gene.
|
This gene is a tumor-specific member of the ECTO-NOX family of genes that encode cell surface NADH oxidases. The encoded protein has two enzymatic activities: catalysis of hydroquinone or NADH oxidation, and protein disulfide interchange. The protein also |
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
Protein | |||||||||||
UniProt ID | Q16206 | ||||||||||
Protein name | Ecto-NOX disulfide-thiol exchanger 2 (APK1 antigen) (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)] | ||||||||||
Protein function | May be involved in cell growth. Probably acts as a terminal oxidase of plasma electron transport from cytosolic NAD(P)H via hydroquinones to acceptors at the cell surface. Hydroquinone oxidase activity alternates with a protein disulfide-thiol i | ||||||||||
Family and domains |
Pfam
|
||||||||||
Tissue specificity | TISSUE SPECIFICITY: Found in the sera of cancer patients with a wide variety of cancers including breast, prostate, lung and ovarian cancers, leukemias, and lymphomas. Not found in the serum of healthy volunteers or patients with disorders other than canc | ||||||||||
Sequence |
|
||||||||||
Sequence length | 610 | ||||||||||
Interactions | View interactions |